Is MediciNova Inc (MNOV) overvalued? · rev $645.4K
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
This page asks whether MediciNova Inc (MNOV) looks expensive on cached numbers — not a short thesis.
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
MNOV currently screens at market cap $66.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MNOV 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MNOV stock page for the full model, not this heading.
Not investment advice.